SecBot SecBot
EFFECT ·Filed Aug 5, 2026

AMIX

Autonomix Medical, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed2mo ago SEC9999999995-26-002539
IPO/offering going effective
Actionable Insight • Neutral

The effective shelf registration introduces a persistent dilution overhang. Traders should monitor for any subsequent prospectus supplements or takedown filings that would signal actual capital-raising and potentially pressure the stock. The cross-filing context points to an effective IPO context combined with shelf context, which acts as an amplifier for impact.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d
AMIX ▼ -62.81% at T+20d
NEUTRAL call -62.81% · α vs SPY -62.21% · entry $12.10 → $4.50
Next anchor: T+60d tomorrow
Latest observation: T+41 -79.76% FF3 residual α
Entry = T+0 close
Aug 5, 2026
via day close
T+1d
+0.58%
call +0.58% · α +0.74%
$12.17
settled 3mo ago
T+5d
-37.73%
call -37.73% · α -38.08%
$7.54
settled 3mo ago
T+20d
-62.81%
call -62.81% · α -62.21%
$4.50
settled 8w ago
T+60d
Pending
tomorrow

Price Chart

Loading chart...

Executive Summary

Autonomix Medical's Form S-3 shelf registration (File No. 333-297760) was declared effective by the SEC on August 4, 2026. This enables the company to offer and sell securities, including common stock, preferred stock, warrants, and units, from time to time at its discretion, creating a potential overhang of future dilution.

Key Facts

  • Effectiveness date: August 4, 2026
  • Registration type: S-3 shelf registration (File No. 333-297760)
  • Company: Autonomix Medical, Inc., a surgical and medical instruments company (market cap ~$19M)
  • Potential issuable securities: common stock, preferred stock, warrants, and units

Financial Impact

No dollar amounts or share counts were disclosed in the EFFECT notice. The shelf registration gives Autonomix the ability to sell an unspecified amount of securities at its discretion.

dilutionshare count

Risk Factors

  • Future offerings could dilute existing shareholders without prior notice
  • Small market cap ($19M) amplifies the dilutive effect of any takedown
  • Potential negative price pressure from the overhang of registered unissued shares

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-002539
Document: 9999999995-26-002539-index.html9999999995-26-002539
Document: 9999999995-26-002539.txt9999999995-26-002539
13 reports for AMIX
Performance horizon
80% Hit rate @ T+20 4 of 5 directional calls Went positive at some point 5 of 5 best @ T+20▲ +52.82%Jul 10, 2026
Filters
Rows
Reports for AMIX — sortable, filterable
TypeNow
Oct 13, 2026
13d ago
3
NEUTRAL ★ 2/10
$3.01awaiting T+20—$2.11 (−29.90%)
Oct 2, 2026
25d ago
Press Release
NEUTRAL ★ 3/10
$3.78awaiting T+20—$2.11 (−44.18%)
Sep 16, 2026
5w ago
8-K
NEUTRAL ★ 3/10
$4.12 $3.01▼ −26.94%▼ −30.12%$2.11 (−48.79%)
Sep 16, 2026
5w ago
EFFECT
BEARISH ★ 7/10
$4.12 $3.01▲ +26.94%▲ +30.12%$2.11 (+48.79%)
Sep 11, 2026
6w ago
424B5
BEARISH ★ 7/10
$4.33 $3.10▲ +28.41%▲ +30.67%$2.11 (+51.27%)
Sep 4, 2026
7w ago
S-3
BEARISH ★ 6/10
$4.58 $3.47▲ +24.24%▲ +25.95%$2.11 (+53.93%)
Aug 26, 2026
8w ago
8-K
MIXED ★ 6/10
$5.63 $4.07▼ −27.71%▼ −27.20%$2.11 (−62.52%)
Aug 5, 2026
11w ago
EFFECT
NEUTRAL ★ 4/10
$12.10 $4.50▼ −62.81%▼ −62.21%$2.11 (−82.56%)
Jul 28, 2026
13w ago
8-K
NEUTRAL ★ 4/10
$2.75 $7.19▲ +161.45%▲ +158.07%$2.11 (−23.27%)
Jul 15, 2026
14w ago
8-K
BEARISH ★ 6/10
$4.92 $6.86▼ −39.43%▼ −35.81%$2.11 (+57.11%)
Showing 10 of 13

US Market Status

Market Open — Closes in 3h 23m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 5, 2026